Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 2/20 | 0.49 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.47 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 3/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | P2RY10 | O00398 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9305139 | 1.00 | MAPT (0.55) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL5981837 | 0.87 | MAPT (0.39) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL26675322 | 0.87 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL11201945 | 0.87 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL22855717 | 0.87 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL8800631 | 0.87 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL22855729 | 0.87 | MAPT (0.71) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL539662 | 0.86 | MAPT (0.58) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL10765993 | 0.86 | MAPT (0.58) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL11801286 | 0.86 | MAPT (0.58) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7138149-B2 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC. (US) | 2006-11-21 | — | — | US | claimed |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC., AN IDAHO CORPORATION | 2004-09-23 | — | — | US | claimed |
| US-6713096-B2 | FOR REDUCING PAIN, INFLAMMATION, STIFFNESS, OR DISCOMFORT IN A MAMMAL | MELALEUCA, INC. | 2004-03-30 | — | — | US | claimed |
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | MELALEUCA, INC. | 2003-07-31 | — | — | US | claimed |
| US-20190246667-A1 | Calcium-Fortified Beverages and Method of Making Thereof | TROPICANA PROD INC (US) | 2019-08-15 | — | — | US | disclosed |
| EP-2222193-B1 | CALCIUM-FORTIFIED BEVERAGES AND METHOD OF MAKING THEREOF | TROPICANA PROD INC (US) | 2015-02-18 | — | — | EP | disclosed |
| US-20150037465-A1 | Calcium-Fortified Beverages and Method of Making Thereof | TROPICANA PRODUCTS, INC. | 2015-02-05 | — | — | US | disclosed |
| EP-2222193-A1 | CALCIUM-FORTIFIED BEVERAGES AND METHOD OF MAKING THEREOF | TROPICANA PRODUCTS, INC. (US) | 2010-09-01 | — | — | EP | disclosed |
| US-20100196578-A1 | Calcium-Fortified Beverages and Method of Making Thereof | TROPICANA PRODUCTS, INC. (US) | 2010-08-05 | — | — | US | disclosed |
| WO-2009085596-A1 | CALCIUM-FORTIFIED BEVERAGES AND METHOD OF MAKING THEREOF | TROPICANA PRODUCTS, INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| US-20090162490-A1 | CALCIUM-FORTIFIED BEVERAGES AND METHOD OF MAKING THEREOF | TROPICANA PRODUCTS, INC. (US) | 2009-06-25 | — | — | US | disclosed |
| US-7138149-B2 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC. (US) | 2006-11-21 | — | — | US | disclosed |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC., AN IDAHO CORPORATION | 2004-09-23 | — | — | US | disclosed |
| US-6713096-B2 | FOR REDUCING PAIN, INFLAMMATION, STIFFNESS, OR DISCOMFORT IN A MAMMAL | MELALEUCA, INC. | 2004-03-30 | — | — | US | disclosed |
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | MELALEUCA, INC. | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | TNF, IL6, IL1B | MAPT 2985/4885LMNA 1216/4885KDM4E 3161/4885 |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | IL6, TNF, IL1B | MAPT 2697/4885LMNA 1793/4885KDM4E 3278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.